No Survival Benefit for Volatile Anesthesia in Elective CABG Surgery No Survival Benefit for Volatile Anesthesia in Elective CABG Surgery
In a comparison of gas versus needle, a new pragmatic trial has shown that using a volatile anesthesia agent during elective coronary-artery bypass grafting (CABG) did not produce fewer deaths after one year.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - March 20, 2019 Category: Surgery Tags: Cardiology News Source Type: news

Volatile Anesthetics Do Not Reduce Deaths in Elective CABG
TUESDAY, March 19, 2019 -- For patients undergoing elective coronary artery bypass grafting (CABG), there is no significant difference in deaths at one year with anesthesia with a volatile agent versus total intravenous anesthesia, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 19, 2019 Category: Pharmaceuticals Source Type: news

Overlapping Surgery Largely Safe
(MedPage Today) -- But study raises questions for CABG and higher-risk patients (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - February 26, 2019 Category: Surgery Source Type: news

Science Saturday: The heart of art
This image is not a medical illustration. It's actually an enhanced CT scan that is as aesthetic as it is instructive. The patient had previously undergone coronary artery bypass surgery. You can see the connection points of the grafts to the aorta. Clips and wires used by the surgeon are also visible. The bypass grafts [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 9, 2019 Category: Databases & Libraries Source Type: news

AtriCure launches CryoIce persistent AF ablation trial
AtriCure (NSDQ:ATRC) said today that it launched a new FDA investigational device exemption cleared trial of its CryoIce system exploring its use in treating persistent atrial fibrillation during concomitant open-chested cardiac surgery. The first patient in the trial has already been treated, the Mason, Ohio-based company said. The initial procedure took place at Takoma Park, Md.’s Washington Adventist Hospital. “Cryothermal energy has been a mainstay of surgical ablation for a long time. The ICE-AFIB IDE trial is the first of its kind designed to assess the safety and sustained effectiveness of cryotherm...
Source: Mass Device - February 5, 2019 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Clinical Trials Surgical AtriCure Inc. Source Type: news

Post-CABG On-Table Extubation Tied to Less Hospital Time
(MedPage Today) -- Average length of stay was 5.6 days for OTE patients (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - January 31, 2019 Category: Surgery Source Type: news

Death at 10 Years Similar With Bilateral-, Single-Artery CABG
WEDNESDAY, Jan. 30, 2019 -- There is no difference in the rate of death from any cause at 10 years for patients undergoing coronary artery bypass grafting (CABG) with bilateral or single internal-thoracic-artery grafting, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 30, 2019 Category: Pharmaceuticals Source Type: news

Post-CABG PCI Tied to Worse Outcomes, Higher Cost
(MedPage Today) -- Death rate of 5.1% in PCI patients exceeded 2.7% rate in those who did not require PCI (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - January 28, 2019 Category: Cardiology Source Type: news

Rivaroxaban Might Not Add Much to Post-CABG Prevention
(MedPage Today) -- Nonsignificant signal for fewer MACE seen in COMPASS substudy (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - January 15, 2019 Category: Cardiology Source Type: news

Not Just Acid Reflux: The Need to Think Worst First
A previously healthy, well-appearing 42-year-old female living in a modern, high-rise apartment in downtown Los Angeles calls 9-1-1 at 5:30 am complaining of worsening of a burning, epigastric pain she had been experiencing for the last three days. She reports associated nausea and non-bloody, non-bilious vomiting, and that she couldn’t manage to get comfortable in bed until she finally decided to call for help at daybreak. During her 9-1-1 call, she reports “pain, like heartburn, that just woke me up again and I had to throw up, … and then I was sweating so much.” Using the Los Angeles Tiered Disp...
Source: JEMS Special Topics - January 13, 2019 Category: Emergency Medicine Authors: Stephen Sanko, MD, FACEP Tags: Exclusive Articles Cardiac & Resuscitation Source Type: news

Villafa ña-led vascular dev Medical 21 registers for $21m offering
St. Jude Medical founder Manny Villafaña’s newest medical play, Medical 21, has registered for an upcoming $10 million equity offering, according to a recently posted SEC filing. The company, which was unveiled in late 2017, is developing an artificial blood vessel as an alternative to harvesting blood vessels for coronary artery bypass surgeries, and has already begun animal testing of the technology. Medical 21 is using a new material developed by the University of Iowa and licensed to the company to make its artificial vessels. The material consists of cellulose graft conduits supported by a thin nitinol wi...
Source: Mass Device - January 8, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Wall Street Beat medical21 Source Type: news

Cardiovascular Care Better at Top-Ranked Hospitals Cardiovascular Care Better at Top-Ranked Hospitals
The US News& World Report's'Best Hospitals'for cardiology provide better care for acute MI, heart failure, and coronary artery bypass surgery than nonranked hospitals, a new analysis confirms.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 4, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

FFR for CABG; Botox Arrhythmia Prevention; Med Device Investigations
(MedPage Today) -- Recent developments of interest in cardiovascular medicine (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - December 3, 2018 Category: Urology & Nephrology Source Type: news

FARGO: No Gain With FFR Over Angiography in Multivessel CABG FARGO: No Gain With FFR Over Angiography in Multivessel CABG
While acknowledging the study's limitations, observers say'the lessons learned from the FFR trials in PCI may not be extrapolated to CABG patients. 'Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 30, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Even at 8 Years, CABG Bests PCI in Diabetes: FREEDOM Extended Even at 8 Years, CABG Bests PCI in Diabetes: FREEDOM Extended
With follow-up time doubled since FREEDOM was reported in 2012, a new analysis suggests the CABG advantage in diabetics with multivessel disease is durable; especially, it hints, in several subgroups.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 28, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

TiCAB: Ticagrelor No Better Than Aspirin 1-Year Post-CABG TiCAB: Ticagrelor No Better Than Aspirin 1-Year Post-CABG
Although hopes for further ticagrelor monotherapy trials after bypass surgery have been squashed, larger dual-antiplatelet therapy outcomes trials are warranted.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 27, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Omega-3 and Vitamin D; Vein Grafts and CABG: It's PodMed Double T! (with audio)
(MedPage Today) -- This week's topics include benefits of CABG, vein harvesting, new exercise guidelines, and omega-3 and vitamin D supplementation (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - November 17, 2018 Category: Neurology Source Type: news

AHA: Lasting Benefit for CABG in Diabetes, Multivessel Disease
THURSDAY, Nov. 15, 2018 -- For patients with diabetes mellitus (DM) with multivessel coronary disease (MVD), coronary revascularization with coronary artery bypass grafting (CABG) is associated with lower all-cause mortality than percutaneous... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 15, 2018 Category: Pharmaceuticals Source Type: news

Bypass Beats Stents in Diabetes With Heart Trouble
People with diabetes who have coronary-artery bypass surgery survive about three years longer than those who have their blood vessels propped open with stents, new research shows. (Source: WebMD Health)
Source: WebMD Health - November 13, 2018 Category: Consumer Health News Source Type: news

REGROUP Lifts Cloud Over Endoscopic Vein Harvesting for CABG REGROUP Lifts Cloud Over Endoscopic Vein Harvesting for CABG
The less invasive approach is favored by patients, but earlier trials suggested safety concerns with endoscopic vein-graft harvesting.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 12, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

AHA: Post-CABG Ticagrelor No Better Than Aspirin
(MedPage Today) -- And safety no better with ticagrelor either (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 12, 2018 Category: Cardiology Source Type: news

AHA: CABG Still Better for Multivessel Disease in Diabetes
(MedPage Today) -- FREEDOM trial extension suggests lower long-term mortality vs stents (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - November 12, 2018 Category: Primary Care Source Type: news

AHA: Endoscopic Vein-Graft Harvesting Redeems Itself in CABG
(MedPage Today) -- Operator expertise takes care of safety concerns (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 11, 2018 Category: Cardiology Source Type: news

TCT: 10 Years On, Surgery for Left Main Disease Edges Stenting
(MedPage Today) -- Separate studies suggest some groups do better with CABG (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - September 25, 2018 Category: Surgery Source Type: news

Diminishing Returns for Off-Pump CABG at 10 Years Diminishing Returns for Off-Pump CABG at 10 Years
New registry data show surgery without cardiopulmonary bypass is associated with increased incomplete revascularization, reintervention, and higher mortality, even in experienced hands.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 19, 2018 Category: Cardiology Tags: Cardiology News Source Type: news

ART: Did Bilateral IMA Bypass Grafts Miss Mark at 10 Years? ART: Did Bilateral IMA Bypass Grafts Miss Mark at 10 Years?
The long-awaited results failed to show that bilateral internal mammary artery grafts are superior conduit for CABG, but some still found reason for optimism.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 27, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

ESC: Two Artery Grafts Better than One in CABG?
(MedPage Today) -- Trial crossovers muddy the outcomes in 10-year study (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - August 26, 2018 Category: Surgery Source Type: news

Specialized approach to open heart surgery saves lives
(Elsevier) Patients who undergo coronary artery bypass grafting (CABG) -- the most common heart surgery performed -- may live longer and experience fewer complications when under the care of a highly focused surgical team that uses simplified and standardized approaches, according to research published today in The Annals of Thoracic Surgery. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 26, 2018 Category: International Medicine & Public Health Source Type: news

Long-term Stroke Rate Higher With CABG vs Stenting Long-term Stroke Rate Higher With CABG vs Stenting
Five-year stroke rates were lower in patients with multivessel or left main coronary artery disease who underwent stenting than in those who had coronary bypass surgery, new research shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 18, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Five-Year Stroke Rates Lower After PCI Versus CABG
WEDNESDAY, July 18, 2018 -- Stroke rates are lower at 30 days and five years after percutaneous coronary intervention (PCI) than after coronary artery bypass grafting (CABG), according to a study published in the July 24 issue of the Journal of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 18, 2018 Category: Pharmaceuticals Source Type: news

Early Strokes Less Common in Multivessel, LM Disease With Stents
(MedPage Today) -- 30-day advantage over CABG was mainly driven by diabetes subgroup (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 16, 2018 Category: Cardiology Source Type: news

Left Main CAD: Treatment Choice Still a Toss-Up
(MedPage Today) -- EXCEL substudies fail to find much difference between PCI and CABG (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 4, 2018 Category: Cardiology Source Type: news

Over-allotment takes Hancock Jaffe IPO to nearly $9m
The underwriter of an initial public offering by Hancock Jaffe Laboratories (NSDQ:HJLI) this week exercised in full its over-allotment option, taking the gross proceeds from the flotation to nearly $9 million. The IPO, which priced on the last day of May, initially brought in $7.5 million for Irvine, Calif.-based Hancock Jaffe, which makes bioprosthetic implants designed to treat chronic deep vein insufficiency, heart valve conditions and coronary artery bypass grafts. The shares trade on the NASDAQ exchange under the symbol “HJLI.” Network 1 Financial Securities, the offering’s managi...
Source: Mass Device - June 15, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Vascular Wall Street Beat hancockjaffelabs Source Type: news

Radial-Artery Grafts Better Than Saphenous-Vein Grafts in CABG
WEDNESDAY, June 6, 2018 -- Compared to saphenous-vein grafts, radial-artery grafts are associated with a lower rate of adverse cardiac events at five-year follow-up in coronary-artery bypass grafting (CABG) patients, according to research published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 6, 2018 Category: Pharmaceuticals Source Type: news

Study shows taking aspirin before or after coronary
(ESA (European Society of Anaesthesiology)) New research presented at this year's Euroanaesthesia congress in Copenhagen, Denmark shows that in patients undergoing a coronary artery bypass graft (CABG) surgery, taking aspirin before and after surgery is associated with an 18 percent to 34 percent reduced mortality risk after four years. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 3, 2018 Category: International Medicine & Public Health Source Type: news

Hancock Jaffe prices $8m IPO below the range
Medical device developer Hancock Jaffe Laboratories yesterday priced its initial public offering below the re-set range it issued last week, raising nearly $8 million. Irvine, Calif.-based Hancock Jaffe makes bioprosthetic implants designed to treat chronic deep vein insufficiency, heart valve conditions and coronary artery bypass graft. Last December the company said it planned to float nearly 1.9 million shares at $6 to $8 apiece, for gross proceeds of $11.3 million to $15.0 million, or $13.1 million at the midpoint. But last week Hancock Jaffe cut the amount of shares to roughly 1.1 million...
Source: Mass Device - June 1, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Wall Street Beat hancockjaffelabs Source Type: news

FFR for CABG; Homeless CVD Care; Alcohol Effect Divergence
(MedPage Today) -- Cardiovascular Daily wraps up the top cardiology news of the week (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - June 1, 2018 Category: Urology & Nephrology Source Type: news

FFR Guidance May Improve CABG Outcomes
(MedPage Today) -- Signal for fractional flow reserve advantage seen in single-center study (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - May 31, 2018 Category: Surgery Source Type: news

CTA Gives Percutaneous Angiography a Run for Its Money CTA Gives Percutaneous Angiography a Run for Its Money
Coronary CT angiography was on a par with conventional percutaneous angiography for answering the question of'CABG or PCI? 'Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 24, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Hancock Jaffe re-sets the range for $8m IPO
Medical device developer Hancock Jaffe Laboratories yesterday re-set the range on a pending initial public offering, which would fetch roughly $8 million at the midpoint. Irvine, Calif.-based Hancock Jaffe makes bioprosthetic implants designed to treat chronic deep vein insufficiency, heart valve conditions and coronary artery bypass graft. Last December the company said it planned to float nearly 1.9 million shares at $6 to $8 apiece, for gross proceeds of $11.3 million to $15.0 million, or $13.1 million at the midpoint. In a new filing yesterday, Hancock Jaffe cut the amount of shares to roughly 1.1 m...
Source: Mass Device - May 23, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Vascular Wall Street Beat hancockjaffelabs Source Type: news

One Botulinum Round Pacifies Postop AF for 3 Years: Pilot Study One Botulinum Round Pacifies Postop AF for 3 Years: Pilot Study
' We don't know why it works, but it's a fascinating new approach,'a discussant said. Botulinum injections into epicardial fat pads at CABG dramatically cut atrial fibrillation burden for up to years later.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 15, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

7 medtech stories we missed this week: May 11, 2018
[Image from unsplash.com]From ReShape submitting an approval application to Health Canada to Conavi receiving FDA clearance, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. ReShape submits for Health Canada approval of ReShape balloon ReShape announced in a May 10 press release that it has submitted an application to the Medical Devices Bureau of the Therapeutic Products Directorate in Canada to amend its existing Canadian medical device license to include distribution of the ReShape Balloon and its accessories. The ReShape Balloon is FDA approved and is a non-s...
Source: Mass Device - May 11, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Cardiovascular Food & Drug Administration (FDA) Hospital Care Imaging mHealth (Mobile Health) Neurological Patient Monitoring Regulatory/Compliance Brainsway Conavi Exact Imaging innovativehealth MedTech PeraHealth qtm Source Type: news

Smoking and Death; Vessels for CABG: It's PodMed Double T! (with audio)
(MedPage Today) -- This week's topics include the best blood vessel for cardiac bypass grafts, rates of autism, five healthy lifestyle factors and their impact on mortality, and managing COPD (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - May 5, 2018 Category: Respiratory Medicine Source Type: news

Radial Artery Outlasts SVG for CABG, Cuts 5-Year Clinical Risk Radial Artery Outlasts SVG for CABG, Cuts 5-Year Clinical Risk
MIs were down at 5 years, and so were repeat revascularizations, after a radial artery graft, vs a vein graft, was added to standard internal thoracic artery bypass -- especially in specific types of patients.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 3, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Radial Artery Use in CABG Improves Outcomes
(MedPage Today) -- Multi-trial analysis shows reduction of major cardiac events (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 1, 2018 Category: Cardiology Source Type: news

Improved Outcomes With Public Reporting of CABG Data
MONDAY, April 30, 2018 -- Mandatory reporting of cardiac surgery outcomes for coronary artery bypass grafting (CABG) in Massachusetts from 2002 to 2014 was associated with improved outcomes, according to a study presented at the annual meeting of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 30, 2018 Category: Pharmaceuticals Source Type: news

Drug Combo Boosts 1-Year CABG Vein Graft Patency (CME/CE)
(MedPage Today) -- Ticagrelor and aspirin together better than aspirin alone (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 24, 2018 Category: Cardiology Source Type: news

Ticagrelor & #43; Aspirin Beneficial After Elective CABG
TUESDAY, April 24, 2018 -- For patients undergoing elective coronary artery bypass grafting (CABG), ticagrelor + aspirin is associated with significantly increased saphenous vein graft patency rates compared with aspirin alone, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 24, 2018 Category: Pharmaceuticals Source Type: news

Hybrid Revasc versus CABG Alone: It's a Toss-Up
(MedPage Today) -- Trial shows no difference in strokes, other events at 5 years (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - April 18, 2018 Category: American Health Source Type: news

Post-CABG AF: Not So Benign
Post-procedure AF, once thought to be an artifact of healing, turns out to be a sign of significant risk, a new study finds. (Source: ConsultantLive)
Source: ConsultantLive - April 10, 2018 Category: Internal Medicine Authors: Payal Kohli, MD Tags: Atrial Fibrillation Source Type: news